Institute of BioMedical Research Corp. (MRES)
0.0030
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Institute of BioMedical Research Net Income (Quarterly) : -0.0515M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0515M |
| March 31, 2026 | -3.266M |
| December 31, 2025 | -0.0567M |
| September 30, 2025 | -0.0682M |
| June 30, 2025 | -0.1091M |
| March 31, 2025 | -0.3003M |
| December 31, 2024 | 0.1358M |
| September 30, 2024 | -0.169M |
| June 30, 2024 | -0.4062M |
| March 31, 2024 | 1.593M |
| December 31, 2023 | 0.3638M |
| September 30, 2023 | -0.2346M |
| June 30, 2023 | -0.3657M |
| March 31, 2023 | 0.1058M |
| December 31, 2022 | -0.2687M |
| September 30, 2022 | -0.218M |
| June 30, 2022 | -0.0526M |
| March 31, 2022 | -0.0464M |
| December 31, 2021 | -0.0471M |
| September 30, 2021 | -0.0618M |
| June 30, 2021 | -0.0118M |
| March 31, 2021 | -0.0115M |
| December 31, 2020 | -0.0112M |
| September 30, 2020 | -0.0109M |
| June 30, 2020 | -0.0107M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0193M |
| December 31, 2019 | -0.0101M |
| September 30, 2019 | -0.0099M |
| June 30, 2019 | -0.0097M |
| March 31, 2019 | 0.018M |
| December 31, 2018 | -0.0092M |
| September 30, 2018 | -0.009M |
| June 30, 2018 | -0.0088M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.1767M |
| March 31, 2015 | 0.2025M |
| December 31, 2014 | 0.1613M |
| September 30, 2014 | 0.0959M |
| June 30, 2014 | 0.1049M |
| March 31, 2014 | 0.6806M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Cavitation Technologies, Inc. | -0.219M |
| Clene, Inc. | -13.42M |
| Bon Natural Life Ltd. | -- |
| Biohaven Ltd. | -137.31M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.025M |
| Total Expenses (Quarterly) | 0.0436M |
| Enterprise Value | 8.641M |
| Profit Margin (Quarterly) | -206.0% |
| Earnings Yield | -10.02% |
| Normalized Earnings Yield | 13.36 |